2026 Pharmaceutical Position Paper
The Committee on Pharmaceutical Affairs has issued a comprehensive set of policy recommendations aimed at bolstering Taiwan’s pharmaceutical supply resilience, ensuring the long-term sustainability of the National Health Insurance (NHI)…






